Literature DB >> 17408929

Update on human prion disease.

Jonathan D F Wadsworth1, John Collinge.   

Abstract

The recognition that variant Creutzfeldt-Jakob disease (vCJD) is caused by the same prion strain as bovine spongiform encephalopathy in cattle has dramatically highlighted the need for a precise understanding of the molecular biology of human prion diseases. Detailed clinical, pathological and molecular data from a large number of human prion disease patients indicate that phenotypic diversity in human prion disease relates in part to the propagation of disease-related PrP isoforms with distinct physicochemical properties. Incubation periods of prion infection in humans can exceed 50 years and therefore it will be some years before the extent of any human vCJD epidemic can be predicted with confidence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17408929     DOI: 10.1016/j.bbadis.2007.02.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  42 in total

Review 1.  Allosteric function and dysfunction of the prion protein.

Authors:  Rafael Linden; Yraima Cordeiro; Luis Mauricio T R Lima
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

2.  Sniffing out a function for prion proteins.

Authors:  Donald A Wilson; Ralph A Nixon
Journal:  Nat Neurosci       Date:  2009-01       Impact factor: 24.884

3.  Anti-bovine prion protein RNA aptamer containing tandem GGA repeat interacts both with recombinant bovine prion protein and its beta isoform with high affinity.

Authors:  Kazuyoshi Murakami; Fumiko Nishikawa; Ken Noda; Takashi Yokoyama; Satoshi Nishikawa
Journal:  Prion       Date:  2008-04-17       Impact factor: 3.931

4.  Accelerated, spleen-based titration of variant Creutzfeldt-Jakob disease infectivity in transgenic mice expressing human prion protein with sensitivity comparable to that of survival time bioassay.

Authors:  Sophie Halliez; Fabienne Reine; Laetitia Herzog; Emilie Jaumain; Stéphane Haïk; Human Rezaei; Jean-Luc Vilotte; Hubert Laude; Vincent Béringue
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

Review 5.  Prion-like mechanisms in neurodegenerative diseases.

Authors:  Bess Frost; Marc I Diamond
Journal:  Nat Rev Neurosci       Date:  2009-12-23       Impact factor: 34.870

Review 6.  Current and future treatment of amyloid diseases.

Authors:  M Ankarcrona; B Winblad; C Monteiro; C Fearns; E T Powers; J Johansson; G T Westermark; J Presto; B-G Ericzon; J W Kelly
Journal:  J Intern Med       Date:  2016-05-10       Impact factor: 8.989

7.  Real-time Quaking-induced Conversion Assay for Detection of CWD Prions in Fecal Material.

Authors:  Yo Ching Cheng; Samia Hannaoui; Theodore Ralph John; Sandor Dudas; Stefanie Czub; Sabine Gilch
Journal:  J Vis Exp       Date:  2017-09-29       Impact factor: 1.355

8.  Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.

Authors:  Emmanuel A Asante; Ian Gowland; Andrew Grimshaw; Jacqueline M Linehan; Michelle Smidak; Richard Houghton; Olufunmilayo Osiguwa; Andrew Tomlinson; Susan Joiner; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

Review 9.  Metal ion physiopathology in neurodegenerative disorders.

Authors:  Silvia Bolognin; Luigi Messori; Paolo Zatta
Journal:  Neuromolecular Med       Date:  2009-11-28       Impact factor: 3.843

10.  Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation.

Authors:  Yvonne S Eisele; Tristan Bolmont; Mathias Heikenwalder; Franziska Langer; Laura H Jacobson; Zheng-Xin Yan; Klaus Roth; Adriano Aguzzi; Matthias Staufenbiel; Lary C Walker; Mathias Jucker
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.